Nov 8 (Reuters)-
Immuno Biological Laboratories Co Ltd
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Sep 30, 2019 Sep 30, 2018 Mar 31, 2020
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 230 mln 384 mln 670 mln
(-40.0 pct) (+15.3 pct) (-14.2 pct)
Operating loss 209 mln loss 37 mln loss 510 mln
Recurring loss 252 mln loss 32 mln loss 640 mln
Net loss 254 mln loss 45 mln loss 655 mln
EPS loss 29.18 yen loss 5.40 yen loss 75.08 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T